ARMISTICE CAPITAL, LLC Q3 2025 Filing
Filed November 17, 2025
Portfolio Value
$6.7B
Holdings
322
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (322 positions)
| Stock | Value |
|---|---|
SPYSPY OCT5 634.0 P | $999.3B |
IWMIWM OCT5 230.0 P | $967.8B |
IWMIWM NOV5 230.0 P | $725.9B |
SPYSPY NOV5 634.0 P | $666.2B |
PTCTPTC THERAPEUTICS ORD | $201.1B |
TVTXTRAVERE THERAPEUTICS ORD | $160.7B |
SUPNSUPERNUS PHARMACEUTICALS ORD | $135.5B |
INCYINCYTE ORD | $99.0B |
NBIXNEUROCRINE BIOSCIENCES ORD | $97.8B |
IMVTIMMUNOVANT ORD | $94.1B |
XRAYDENTSPLY SIRONA ORD | $72.8B |
REGNREGENERON PHARMACEUTICALS ORD | $70.4B |
FRPTFRESHPET ORD | $68.0B |
AMZNAMAZON COM ORD | $67.9B |
CYTKCYTOKINETICS ORD | $65.8B |
GEHCGE HEALTHCARE TECHNOLOGIES ORD | $59.7B |
EXASEXACT SCIENCES ORD | $56.4B |
GOOGLALPHABET CL A ORD | $56.1B |
MDGLMADRIGAL PHARMACEUTICALS ORD | $55.0B |
CYTKCYTK JAN7 40.0 C | $52.2B |
FIVNFIVE9 ORD | $48.4B |
MSFTMICROSOFT ORD | $45.2B |
ARGXARGENX ADR REP ORD | $42.8B |
TMCITREACE MEDICAL CONCEPTS ORD | $42.4B |
KURAKURA ONCOLOGY ORD | $41.3B |
NVONOVO NORDISK ADR REPSG 1 ORD | $40.8B |
PENNPENN ENTERTAINMENT ORD | $40.5B |
DYNDYNE THERAPEUTICS ORD | $38.8B |
MDGLMDGL JAN6 400.0C | $36.7B |
MDBMONGODB CL A ORD | $34.9B |
OFIXORTHOFIX MEDICAL ORD | $32.7B |
AGIOAGIOS PHARMACEUTICALS ORD | $30.7B |
SBUXSTARBUCKS ORD | $30.1B |
IMCRIMMUNOCORE HOLDINGS ADR | $29.9B |
BMYBRISTOL MYERS SQUIBB ORD | $29.3B |
AVNSAVANOS MEDICAL ORD | $28.9B |
SNYSANOFI 2 ADR REP ORD | $28.9B |
IRONDISC MEDICINE ORD | $28.8B |
DDOGDATADOG CL A ORD | $28.8B |
AGIOAGIO FEB6 40.0 C | $28.1B |
BABAALIBABA GROUP HOLDING ADR REP 8 ORD | $27.9B |
TMOTHERMO FISHER SCIENTIFIC ORD | $26.7B |
AUTLAUTOLUS THERAPEUTICS ADR | $25.4B |
MDTMEDTRONIC ORD | $25.3B |
SS MAR6 18.0 C | $24.7B |
NBISNEBIUS CL A ORD | $23.9B |
BCYCBICYCLE THERAPEUTICS ADR | $23.0B |
MDGLMDGL APR6 400.0C | $22.9B |
GRFSGRIFOLS ADR REP ONE NON VTG CL B ORD | $22.3B |
CVSCVS HEALTH ORD | $22.0B |
AXGNAXOGEN ORD | $21.4B |
IRWDIRONWOOD PHARMA CL A ORD | $21.2B |
HUBSHUBSPOT ORD | $21.1B |
RI2RIGEL PHARMACEUTICALS ORD | $20.5B |
VYGRVOYAGER THERAPEUTICS ORD | $19.6B |
SSENTINELONE CL A ORD | $19.6B |
DTDYNATRACE ORD | $19.4B |
MLYSMINERALYS THERAPEUTICS ORD | $19.3B |
VSTMVERASTEM ORD | $18.5B |
RHRH ORD | $18.4B |
ISRGINTUITIVE SURGICAL ORD | $18.3B |
ANGOANGIODYNAMICS ORD | $18.3B |
PATHUIPATH CL A ORD | $18.0B |
PRTAPROTHENA ORD | $17.8B |
ELFELF BEAUTY ORD | $17.6B |
RBLXROBLOX CL A ORD | $17.4B |
GTLBGITLAB CL A ORD | $17.0B |
ROSTROSS STORES ORD | $16.9B |
TSMTAIWAN SEMICONDUCTOR MNFTG ADR 5 ORD | $15.8B |
VRTXVERTEX PHARMACEUTICALS ORD | $15.8B |
FIVNFIVN JUL6 27.5 C | $15.7B |
CTORCITIUS ONCOLOGY ORD | $15.6B |
VERAVERA THERAPEUTICS CL A ORD | $15.6B |
NKTRNEKTAR THERAPEUTICS ORD | $15.2B |
WYNNWYNN RESORTS ORD | $15.0B |
WDAYWORKDAY CL A ORD | $14.7B |
NVDANVIDIA ORD | $14.4B |
APPAPPLOVIN CL A ORD | $14.0B |
NPCENEUROPACE ORD | $13.4B |
HUMHUMANA ORD | $13.4B |
UBERUBER TECHNOLOGIES ORD | $11.8B |
NTLAINTELLIA THERAPEUTICS ORD | $11.6B |
EWEDWARDS LIFESCIENCES ORD | $11.4B |
RDDTREDDIT CL A ORD | $11.3B |
ULTAULTA BEAUTY ORD | $11.1B |
TOSTTOAST CL A ORD | $10.4B |
ARVNARVINAS ORD | $10.2B |
MGNXMACROGENICS ORD | $10.0B |
LENLENNAR CL A ORD | $9.9B |
BRBRBELLRING BRANDS ORD | $9.9B |
FDMT4D MOLECULAR THERAPEUTICS ORD | $9.5B |
CNTACENTESSA PHARMACEUTICALS ADR | $9.2B |
CHRCHURCHILL DOWNS ORD | $9.1B |
NUVBNUVATION BIO CL A ORD | $8.5B |
AGIOAGIO DEC5 40.0 C | $8.0B |
BSXBOSTON SCIENTIFIC ORD | $7.8B |
HHYATT HOTELS CL A ORD | $7.7B |
ORLYO REILLY AUTOMOTIVE ORD | $7.6B |
MCDMCDONALD'S ORD | $7.2B |
BBYBEST BUY ORD | $7.2B |
Page 1 of 4Next